The United Arab Emirates has entered a transformative phase in cardiac treatment with the introduction of pulse field ablation (PFA), a groundbreaking medical procedure that significantly enhances atrial fibrillation treatment. This innovative approach, currently being implemented at Al Qassimi Hospital, represents a monumental leap forward in electrophysiological interventions.
Medical experts describe PFA technology as ushering in “a new era” of cardiac care by dramatically reducing procedural duration from approximately three hours to a mere 30 minutes. The technique specifically addresses atrial fibrillation, recognized globally as the most prevalent heart rhythm disorder. Unlike conventional methods that necessitate general anesthesia, this advanced procedure can be performed using conscious sedation, substantially minimizing patient risk and discomfort.
Dr. Mohamed Magdy Abbas, Consultant and Head of the EP unit at Al Qassimi Hospital, emphasized the profound clinical implications during discussions at the World Health Expo in Dubai. The Volt system catheter technology enables real-time visualization of heart tissue contact while achieving unprecedented precision in targeting abnormal electrical signals. This specificity has resulted in complication rates plummeting from 7% to just 2%.
The medical benefits extend far beyond procedural efficiency. This advanced treatment modality demonstrates a remarkable 25% reduction in stroke risk among patients by effectively preventing heart failure progression. Furthermore, recovery timelines have been radically compressed, with studies exploring the feasibility of same-day discharge protocols.
Post-procedure monitoring incorporates sophisticated subcutaneous chips that continuously track cardiac rhythms, providing clinicians with comprehensive data for optimal patient management. Early outcomes indicate significantly lower recurrence rates compared to traditional radiofrequency and cryo ablation techniques.
This medical innovation promises substantial improvements in quality of life, disability prevention, and long-term cardiovascular health outcomes. As the technology continues to evolve, UAE healthcare institutions position themselves at the forefront of cardiac care innovation, potentially establishing new global standards in arrhythmia treatment.